Form 8-K - Current report:
SEC Accession No. 0000950170-21-004812
Filing Date
2021-11-19
Accepted
2021-11-19 16:29:41
Documents
12
Period of Report
2021-11-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K rkda-20211115.htm   iXBRL 8-K 46642
  Complete submission text file 0000950170-21-004812.txt   163995

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rkda-20211115_lab.xml EX-101.LAB 13496
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rkda-20211115.xsd EX-101.SCH 2503
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rkda-20211115_pre.xml EX-101.PRE 11087
5 EXTRACTED XBRL INSTANCE DOCUMENT rkda-20211115_htm.xml XML 4678
Mailing Address 4222 E. THOMAS RD SUITE 320 PHOENIX X1 85018
Business Address 202 COUSTEAU PLACE SUITE 200 DAVIS X1 95618 602-429-0471
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37383 | Film No.: 211428714
SIC: 0100 Agricultural Production-Crops